논문 13 페이지 | PnH

최근소식

회사소개 사업소개 치료기술 암종별치료 최근소식 고객센터

논문 치료사례 동영상게시판 사진게시판

논문

번호 제목 날짜

230

2024년 Journal for ImmunoTherapy of Cancer:Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis

2024년 Journal for ImmunoTherapy of Cancer:Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis
2024-05-31
229

2024년 National Science Review:Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor

2024년 National Science Review:Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor
2024-05-31
228

2024년 Blood:Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001

2024년 Blood:Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001
2024-05-31
227

2024년 Blood Advances:Impact of diagnostic investigations in the management of CAR T-cell-associated neurotoxicity

2024년 Blood Advances:Impact of diagnostic investigations in the management of CAR T-cell-associated neurotoxicity
2024-05-31
226

2024년 Nature Medicine:Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

2024년 Nature Medicine:Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial
2024-05-31
225

2024년 Blood:Second Primary Malignancies After Commercial CAR T Cell Therapy: Analysis of FDA Adverse Events Reporting System (FAERS)

2024년 Blood:Second Primary Malignancies After Commercial CAR T Cell Therapy: Analysis of FDA Adverse Events Reporting System (FAERS)
2024-05-31
224

2024년 New England Journal of Medicine:Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

2024년 New England Journal of Medicine:Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
2024-05-31
223

2024년 Molecular Cancer:The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments

2024년 Molecular Cancer:The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments
2024-05-31
222

2024년 Nature Medicine:Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

2024년 Nature Medicine:Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
2024-05-31
221

2024년 New England Journal of Medicine"(NEJM): Intraventrcular CARv3-TEAM-E T Cells in Research

2024년 New England Journal of Medicine"(NEJM): Intraventrcular CARv3-TEAM-E T Cells in Research
2024-05-31